Bart Roelf Jan van Dijken
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 28, 2023
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?Bart R J van Dijken, Annerieke R Doff, Roelien H Enting
|Sep 09, 2023
The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma.Bart R J van Dijken, Hanne-Rinck Jeltema, Justyna Kłos
|May 03, 2023
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.Jesse D de Groot, Bart R J van Dijken, Hiska L van der Weide
|Feb 25, 2022
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.Bart R J van Dijken, Alfred O Ankrah, Gilles N Stormezand
|Jun 11, 2021
Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.Bart R J van Dijken, Bram Schuuring, Hanne-Rinck Jeltema
|Jan 11, 2021
Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation.Bart Roelf Jan van Dijken, A van der Hoorn
Pageof 1
